| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jun―05 |
From pandemic to preparedness: CEPI 3.0 and the road to the 100 Days Mission |
Mark Lucera |
| 2 |
[GO] |
2026―Apr―09 |
Modulation of antitumor immunity by COVID-19 mRNA vaccination: retrospective association, mechanistic evidence, and need for prospective validation |
Adam Grippin |
| 3 |
[GO] |
2026―Apr―08 |
Towards a coherent Nordic vision for vaccine R&D, manufacturing, and pandemic preparedness |
Catherine Fleck-Vidal, Mike Whelan, Ingrid Kromann, Niels Thulstrup, Katie Smith, Bjørg Dystvold Nilsson, Tung Thanh Le, Sally Girgis-Hjoberg, Stig Tollefsen, T Anh Wartel, Laura Plant |
| 4 |
[GO] |
2026―Jan―19 |
Pioneering technological innovation and sustainability in vaccine manufacturing to ensure pandemic preparedness and global access |
Anca Tacu, Martina Micheletti, Stephen Morris, Brenda Parker |
| 5 |
[GO] |
2025―Dez―16 |
Advanced technologies enabling accessible and sustainable vaccine development and manufacturing for future pandemics |
June Kim, Anna Särnefält |
| 6 |
[GO] |
2025―Dez―16 |
A holistic approach to pandemic preparedness: exploring the importance of integrated advice |
Anja Schreijer, Tomris Cesuroglu |
| 7 |
[GO] |
2025―Dez―16 |
Pandemic preparedness and the future of RNA therapeutics: RNA readiness and response |
Duccio Medini |
| 8 |
[GO] |
2025―Dez―16 |
The role of African scientists in pandemic preparedness |
Evelyn Gitau, Uzma Alam, Caxton Murira, Linda Murungi |
| 9 |
[GO] |
2025―Dez―10 |
A career in containment: insights from the epicenter of WHO’s COVID-19 response |
Maria Van Kerkhove |
| 10 |
[GO] |
2024―Mai―02 |
Maintaining ‘warm base’ capacity for pandemic preparedness |
Kilian Mullett |
| 11 |
[GO] |
2024―Mrz―14 |
Exploring hybrid mRNA vaccine technology for lasting immunity to COVID-19 |
Magnus Hoffmann |
| 12 |
[GO] |
2024―Mrz―14 |
Avian influenza and the risk of pandemic |
Mathilde Richard |
| 13 |
[GO] |
2023―Sep―13 |
Testing in times of COVID-19: legacy & unfinished agenda |
Carolina Batista, Yanis Ben Amor, Onder Ergonul, Peter Figueroa, Sarah C. Gilbert, Mayda Gursel, Emma Hannay, Mazen Hassanain, Peter Hotez, Gagandeep Kang, Jerome Kim, Bhavna Lall, Heidi Larson, Sarah-Jane Loveday, Denise Naniche, Timothy Sheahan, Shmuel Shoham, Nathalie Strub-Wourgaft, Samba Sow, Annelies Wilder-Smith, Prashant Yadav, Joe Fitchett, Amadou Sall, Maria Elena Bottazzi |
| 14 |
[GO] |
2023―Sep―13 |
Veterinary coronavirus vaccines: successes, challenges & lessons learned for SARS-CoV-2 control |
Anna Hassebroek, Xiang-Jin Meng |
| 15 |
[GO] |
2023―Sep―13 |
Unpacking the vaccine clinical trial ecosystem: implementing adaptive design, leveraging pandemic experience, & supporting resource-limited settings |
Sushant Sahastrabuddhe |
| 16 |
[GO] |
2023―Sep―07 |
Developing optimal pediatric COVID-19 vaccines for children younger than 12 years during an evolving pandemic |
Flor M Muñoz, Charu Sabharwal, Alejandra Gurtman, Emmanuel B Walter, Grant C Paulsen, Eric AF Simões, Caitlin Hansen, Luke Cunliffe, Stephen Lockhart, Hua Ma, Xia Xu, Kenneth Koury, Kena A Swanson, Nicholas Kitchin, William C Gruber, Annaliesa S Anderson |
| 17 |
[GO] |
2023―Sep―07 |
Lessons from COVID-19: how can vaccine clinical trials adapt to emerging threats? |
Daniel Hoft |
| 18 |
[GO] |
2023―Aug―08 |
Development of recombinant vesicular stomatitis virus vaccine platform for rapid response to Ebola and COVID-19 outbreaks |
Christopher Ton, Michael A Winters, Raymond Ducoat, Douglas D Richardson, Kristine Fuller, Melissa Hughes |
| 19 |
[GO] |
2023―Aug―08 |
Pandemic preparedness: the vaccine manufacturer’s perspective |
Jane True |
| 20 |
[GO] |
2023―Aug―08 |
Rapid manufacturing of vaccines for pandemic response & personalized cancer: parallels to leverage for common pathways to expedite clinical development? |
Antu K. Dey |
| 21 |
[GO] |
2023―Aug―08 |
OPENCORONA: lessons learned from a pandemic vaccine consortium |
Matti Sällberg, Eva-Karin Gidlund |
| 22 |
[GO] |
2023―Aug―02 |
Developing mRNA influenza vaccines in the wake of COVID-19 |
Raffael Nachbagauer |
| 23 |
[GO] |
2023―Aug―01 |
Vaccine supply chains: priority areas of action emerging from the COVID-19 pandemic |
Prashant Yadav, Carolina Batista, Ravi Anupindi, Sarah C. Gilbert, Bhavna Lall, Shmuel Shoham, Mayda Gursel, Yanis Ben Amor, Jerome Kim, Heidi Larson, Peter Figueroa, Nathalie Strub-Wourgaft, Samba Sow, Mazen Hassanain, Maria Elena Bottazzi, Peter Hotez |
| 24 |
[GO] |
2023―Jan―31 |
Why vaccinate children against COVID-19? |
David C Kaslow, Carolina Batista, Maria Elena Bottazzi, Onder Ergonul, J Peter Figueroa, Mayda Gursel, Mazen Hassanain, Peter Hotez, Gagandeep Kang, Bhavna Lall, Heidi Larson, Denise Naniche, Timothy Sheahan, Samba O Sow, Nathalie Strub-Wourgaft, Prashant Yadav, Annelies Wilder-Smith |
| 25 |
[GO] |
2023―Jan―31 |
Sourcing quality raw & starting materials at a reasonable cost during the pandemic |
Caryn Fenner |
| 26 |
[GO] |
2023―Jan―31 |
Discovery to delivery in 100 days: RNA therapeutics & their role in future pandemic preparedness |
Tracy Humphries |
| 27 |
[GO] |
2022―Aug―17 |
EATRIS: providing the right tools, at the right time, for vaccine development in a pandemic |
David Morrow, Lucia Gabriele, Antonio Andreu, Florence Bietrix, Anton Ussi, Jan Langermans |
| 28 |
[GO] |
2022―Jul―11 |
Vaccine development in the COVID-19 era: regulatory challenges & innovation |
Peter Marks, Marco Cavaleri, Carla Vinals, Adam Hacker |
| 29 |
[GO] |
2022―Jul―11 |
COVID-19 vaccine supply chain management: a LMIC perspective |
Darin Zehrung |
| 30 |
[GO] |
2022―Jul―11 |
COVID-19 vaccine supply chain management: a US perspective |
Michael Angelastro, Robert A Johnson |
| 31 |
[GO] |
2022―Jul―11 |
COVID-19: how is the pandemic changing the vaccines space? |
Nicholas Jackson |
| 32 |
[GO] |
2022―Jul―11 |
Guiding America through a pandemic |
Anthony S Fauci |
| 33 |
[GO] |
2022―Jul―11 |
Developing broadly protective strategies to protect against future pandemic threats |
Ralph Baric |
